跳到正文
American Journal of Human Genetics· Paulo C.M. Lyra, Samuel Brito, Michael Parsons, Chunling Hu, Thales C. Nepomuceno, Nam Phuong Nguyen, Lucas Dalcolmo, Marcy E. Richardson, Geise de Oliveira, João da Silva, Laura Caleca, Huaizhi Huang, Sounak Sahu, Muthiah Bose, Maria Rossing, Phoebe Dace, Gregory M. Findlay, Rehan Villani, Aditi Hazra, Alexandra Martins, Sandrine M. Caputo, Gael A. Millot, Joanne Ngeow Yuen Yie, Marcelo A. Carvalho, Melissa S. Cline, Paolo Radice, Romy L.S. Mesman, Valentina Zampiga, Vijai Joseph, Katherine L. Nathanson, Kyriaki Michailidou, Edwin S. Iversen, Shyam Sharan, Amanda B. Spurdle, Maaike P.G. Vreeswijk, Fergus J. Couch, Alvaro N.A. Monteiro, the ENIGMA Consortium·精选AI 评分78

整合 9,424 个 BRCA1/BRCA2 错义变异功能数据,按 ClinGen 指南分类 6,517 个意义未明变异

Large-scale integration of functional assay data for the resolution of germline BRCA1 and BRCA2 variants of uncertain significance

AI 导读

Lyra, Jr. 等人整合并统一了 9,424 个 BRCA1 和 BRCA2 错义变异的功能实验数据,按 ClinGen 指南建立整合框架,其致病性判定与乳腺癌风险相符。结合功能数据与其他证据,共完成 6,517 个错义变异的分类,结果发表于 American Journal of Human Genetics。上述信息只来自摘要,未给出分类一致性及风险关联的具体效应量。

原文摘要

出版方登记 · OpenAlex

Carriers of BRCA1 and BRCA2 pathogenic variants are at a significantly elevated risk for several cancers. Widespread germline genetic testing has led to a significant increase in the detection of variants of uncertain significance (VUSs) in these genes. To assess variant pathogenicity, we curated, harmonized, and integrated functional data for 3,247 BRCA1 and 6,177 BRCA2 missense variants derived from BRCA1/2 functional assays. Functional results were harmonized across studies by converting data into ordinal categorical variables. We applied ClinGen variant interpretation guidelines for each assay to assign evidence for or against pathogenicity. Final evidence criteria for each variant were obtained through the integration of results from different assays, and large case-control studies confirmed that benign and pathogenic variants categorized using the integrated functional framework are associated with low and high risk for breast cancer, respectively. Next, we integrated additional sources of data, leading to resolution of 80.1% of BRCA1 VUSs and 69.5% of BRCA2 VUSs and classification of 6,517 (2,345 in BRCA1 and 4,172 in BRCA2) missense variants.

页面未能读取全文,以上为出版方登记的摘要;方法与图表见原文

推荐理由

把分散的功能实验数据整合成可对照乳腺癌风险判读的 BRCA1/BRCA2 变异分类框架,可用于临床变异解读。

来源:American Journal of Human Genetics · cell.com